Pharmaceuticals

Imaging eBook
#Drug development #Drug discovery #Imaging #Magnetic Resonance Imaging (MRI) #Pharmaceuticals #Technology

Imaging and drug discovery: Applications and innovations

This latest eBook sponsored by Bethyl Laboratories/Fortis Life Science features expert opinions on how imaging technologies are informing drug discovery and bringing more insight into treating diseases. Download this exclusive eBook to learn more about: The importance of imaging innovations in the fight against cancer How magnetic resonance imaging (MRI)… Read More

#DDW eBooks #Intelligence

#Business #Drug development #Drug discovery #Marketing #Pharmaceuticals #Regulatory

The three key stages to a successful specialty drug launch

Listen to this article on the DDW Podcast: Craig Caceci, Managing Director at Terebellum, offers guidance to pharmaceutical companies that are in the position to take their drugs to market.  In today’s competitive environment, a winning, fail-safe drug launch strategy is more important than ever, especially with increased NHS and private… Read More

#Exclusive Content #Regulatory

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Data science #Drug development #Drug discovery #Pharmaceuticals

AI is critical to solving new complexities in drug discovery

Listen to this article on the DDW Podcast: Andrew A Radin Chief Executive Officer of Aria Pharmaceuticals, on the critical use of artificial intelligence in solving some of drug discovery’s most new and complex challenges. Basic research and new technologies are uncovering insights every day that build on our understanding of human… Read More

#Exclusive Content

UK
#Association of the British Pharmaceutical Industry #Immunology / Virology & Vaccines #Moderna #mRNA #Pharmaceuticals #Therapeutics

Moderna joins the Association of the British Pharmaceutical Industry 

Moderna has become the newest member of the UK’s pharmaceutical industry body, the Association of the British Pharmaceutical Industry (ABPI), building on the long-term commitment by the American-based company to expand its footprint and investment in the UK.  Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics… Read More

#News

#AbbVie #ABPI #Clinical trials #Eli Lilly #Life sciences #Pharmaceutical industry #Pharmaceuticals #UK #UK government

Pharma firms pull out of UK drug pricing agreement

AbbVie and Eli Lilly have left the voluntary medicines pricing agreement in protest over what they describe as “increasingly punitive revenue clawbacks”.  The companies have left the UK’s Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), a long-standing agreement between government and industry with roots going back to the… Read More

#Business & Investment #News #Trending News

#Clarivate #Drug development #Drug discovery #Market reporting #Personalised medicine #Pharmaceuticals

15 drugs likely to be clinical game-changers

A new report highlights promising therapeutic developments for HIV, Parkinson’s disease, Crohn’s disease, alopaecia, multiple myeloma and breast cancer on the horizon, with personalised medicines strongly represented.  Analysts Clarivate have identified 15 late-stage experimental treatments that are each forecast to deliver annual sales of more than $1 billion within five… Read More

#Exclusive Content #Trends & Analysis

Non-alcoholic fatty liver disease
#China #Clinical trials #Liver disease #Market reporting #Pharmaceuticals

China’s clinical trial activity in NAFLD increasing

China is expected to record the highest diagnosed prevalence of non-alcoholic fatty liver disease (NAFLD) in 2029, representing 44% of cases within the 16 major pharmaceutical markets (16MM).   As a result, the number of clinical trials conducted in the country for this indication is gradually increasing, driven mostly by international… Read More

#Business & Investment #News

Batch testing pharmaceuticals
#ABPI #Batch testing #EU #Pharmaceuticals #Testing #UK

UK clarifies post-BREXIT batch testing rules for pharmaceuticals 

The UK government has announced its future strategy for batch testing of medicinal products.  The new strategy means that the UK will continue to recognise batch testing from the EU/EEA, rather than insisting on duplicative batch testing operations.  Post-BREXIT, the pharmaceutical industry urged the UK… Read More

#News

Central nervous system
#CNS #Collaboration #Genetics / genomics #Partnership #Pharmaceuticals #Research & development #Target identification

Collaboration will focus on therapy targets for CNS disorders

PrecisionLife and Ono Pharmaceutical have agreed a multi-target discovery and validation partnership.   The R&D collaboration will leverage PrecisionLife’s combinatorial analytics-generated insights to identify novel therapeutic targets and patient stratification biomarkers in central nervous system (CNS) disorders for development by Ono.  PrecisionLife analyses multi-modal datasets including genomic, clinical, and epidemiological data… Read More

#Business & Investment #News

#Drug development #Generics #Patent Law #Pharmaceuticals #Polymorphism #Small molecules

Polymorph profiling with X-ray powder diffraction protects patents and patients

By Dr Natalia Dadivanyan, Segment Marketing Manager, Malvern Panalytical  Small molecules can face big challenges  Despite the emergence of, and excitement around, advanced therapeutic modalities, traditional small molecule pharmaceuticals still occupy a significant and steadily growing share of the market. A recent report indicated the current market size to be ~$166… Read More

#Business & Investment #Exclusive Content

#Biopharmaceuticals #Drug discovery #Drug targets #Drug technology #Pharmaceuticals #Quantum computing #R&D #Therapeutics

Podcast: Complex problems require complex solutions

This is the latest episode of the free DDW podcast, “Complex problems require complex solutions”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “How quantum computing can benefit drug discovery” and “Sitting down with Dr Michael Hayden from… Read More

#News

#Drug discovery #Patent Law #Pharmaceuticals #Regulatory

Navigating the growing labyrinth of pharma disputes 

Michael Frisby, Partner at Stevens & Bolton LLP, examines where legal disputes are likely to occur within the pharmaceutical industry.  The current economic environment has fuelled fears of recession and with it a rise in disputes. But where are disputes likely to arise for life sciences businesses and what can… Read More

#Regulatory

#Business #GSK #Immunology / Virology & Vaccines #Pharmaceuticals

GSK reports strong Q3 results  

GSK has announced strong quarterly results, reporting sales of £7.8 billion and growth in various sectors of the business.   Overall, the company’s adjusted operating profit for the third quarter came in at £2.6 billion, a 17% increase compared to the same period last year and reflecting a 4% year-on-growth at… Read More

#Business & Investment

#Biologics #Life sciences #Pharmaceuticals

Podcast: The changing drug discovery landscape

This is the latest episode of the free DDW podcast, “What does the changing drug discovery and development landscape mean for the future?”. It covers three articles written for Volume 22, Issue 4 – Fall 2021 of DDW, narrated by DDW Multimedia Editor Megan Thomas. They are called “The… Read More

#News

#Contract development and manufacturing organisations #Drug discovery #Manufacturing #Pharmaceuticals

Maximising outsourcing models beyond time and cost

In this listicle, SAMDITech outlines the benefits of outsourcing models in the pharmaceutical industry, looking past perceived costs to the value outsourcing can bring.   Many biotech and pharmaceutical companies now  rely on contract research organisations (CROs) for drug discovery services. CROs offer an established infrastructure to develop, initiate, execute,… Read More

#News

Seoul, South Korea
#Korea #Pharmaceuticals

Korean pharma “booming” survey finds

The results of the survey were revealed ahead of CPHI Korea, which will be held in Seoul, September 28-30. South Korea recovered from the pandemic earlier than many other Asian countries and reported rapid growth in its contract manufacturing industry in the last two years.  In fact, the government… Read More

#News